NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 264 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $287,825 | -12.8% | 3,924 | -9.6% | 0.01% | -16.7% |
| Q3 2022 | $330,000 | +7.1% | 4,340 | -2.1% | 0.01% | +20.0% |
| Q2 2022 | $308,000 | -19.4% | 4,431 | -3.9% | 0.01% | 0.0% |
| Q1 2022 | $382,000 | +9.5% | 4,612 | -0.8% | 0.01% | 0.0% |
| Q4 2021 | $349,000 | -38.2% | 4,651 | -4.4% | 0.01% | -37.5% |
| Q3 2021 | $565,000 | -50.1% | 4,863 | -4.7% | 0.01% | -50.0% |
| Q2 2021 | $1,132,000 | +63.6% | 5,102 | -2.6% | 0.02% | +45.5% |
| Q1 2021 | $692,000 | -25.4% | 5,239 | -2.3% | 0.01% | -26.7% |
| Q4 2020 | $928,000 | +45.7% | 5,363 | -6.3% | 0.02% | +25.0% |
| Q3 2020 | $637,000 | +83.6% | 5,724 | -2.2% | 0.01% | +71.4% |
| Q2 2020 | $347,000 | -11.0% | 5,854 | +1.1% | 0.01% | -30.0% |
| Q1 2020 | $390,000 | +13.0% | 5,791 | +41.6% | 0.01% | +42.9% |
| Q4 2019 | $345,000 | +84.5% | 4,090 | +64.0% | 0.01% | +75.0% |
| Q3 2019 | $187,000 | +15.4% | 2,494 | -2.4% | 0.00% | 0.0% |
| Q2 2019 | $162,000 | +12.5% | 2,555 | -14.5% | 0.00% | +33.3% |
| Q1 2019 | $144,000 | +1.4% | 2,989 | -29.4% | 0.00% | -25.0% |
| Q4 2018 | $142,000 | – | 4,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |